Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 0.66 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.57 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9167621 | 1.00 | CYP19A1 (0.66) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL17817183 | 1.00 | CYP19A1 (0.66) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL9165752 | 1.00 | CYP19A1 (0.66) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL30292299 | 1.00 | CYP19A1 (0.66) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL9127581 | 1.00 | CYP19A1 (0.66) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL27740868 | 0.96 | MAPT (0.62) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL5171515 | 0.94 | MAPT (0.58) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL29375687 | 0.91 | MAPT (0.60) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL7702894 | 0.91 | MAPT (0.60) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA | |
| SCHEMBL4908553 | 0.89 | CYP19A1 (0.61) | CYP19A1CYSLTR2CYSLTR1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110080458-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2011-04-07 | — | — | US | disclosed |
| US-7704667-B2 | Dyes and use thereof in imaging members and methods | ZINK IMAGING, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-20080187866-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-08-07 | — | — | US | disclosed |
| US-20070224552-A1 | PROCESS FOR THE PREPARATION OF NOVEL DYES FOR USE IN IMAGING MEMBERS | ZINK IMAGING, LLC | 2007-09-27 | — | — | US | disclosed |
| US-7220868-B2 | Process for the preparation of novel dyes for use in imaging members | ZINK IMAGING, LLC (US) | 2007-05-22 | — | — | US | disclosed |
| US-20060234143-A1 | Process for the preparation of novel dyes for use in imaging members | ZINK IMAGING, LLC | 2006-10-19 | — | — | US | disclosed |
| US-7008759-B2 | Dyes and use thereof in imaging members and methods | POLAROID CORPORATION (US) | 2006-03-07 | — | — | US | disclosed |
| US-20040191668-A1 | Novel dyes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-30 | — | — | US | disclosed |
| WO-2004078875-A2 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080187866-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | CACYBP, KLHDC2, ZKSCAN2 | CYP19A1 4026/4885CYSLTR2 3588/4885CYSLTR1 3026/4885 |
| US-20070224552-A1 | PROCESS FOR THE PREPARATION OF NOVEL DYES FOR USE IN IMAGING MEMBERS | CACYBP, ZKSCAN2, CRYAB | CYP19A1 4069/4885CYSLTR2 4334/4885CYSLTR1 3881/4885 |
| US-20110080458-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | CACYBP, KLHDC2, ZKSCAN2 | CYP19A1 4026/4885CYSLTR2 3588/4885CYSLTR1 3026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.